nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP3A4—Temozolomide—melanoma	0.278	0.385	CbGbCtD
Vilazodone—CYP2D6—Vemurafenib—melanoma	0.239	0.332	CbGbCtD
Vilazodone—CYP3A4—Vemurafenib—melanoma	0.152	0.211	CbGbCtD
Vilazodone—CYP3A4—Docetaxel—melanoma	0.0522	0.0724	CbGbCtD
Vilazodone—Connective tissue disorder—Vemurafenib—melanoma	0.00341	0.0203	CcSEcCtD
Vilazodone—Dry eye—Temozolomide—melanoma	0.00326	0.0194	CcSEcCtD
Vilazodone—Eye disorder—Vemurafenib—melanoma	0.00324	0.0193	CcSEcCtD
Vilazodone—Cardiac disorder—Vemurafenib—melanoma	0.00322	0.0192	CcSEcCtD
Vilazodone—Malnutrition—Vemurafenib—melanoma	0.00302	0.018	CcSEcCtD
Vilazodone—Dysgeusia—Vemurafenib—melanoma	0.00296	0.0176	CcSEcCtD
Vilazodone—Gastroenteritis—Temozolomide—melanoma	0.00289	0.0172	CcSEcCtD
Vilazodone—Hyponatraemia—Carmustine—melanoma	0.00266	0.0159	CcSEcCtD
Vilazodone—Arthralgia—Vemurafenib—melanoma	0.00257	0.0153	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00255	0.0152	CcSEcCtD
Vilazodone—Nervous system disorder—Vemurafenib—melanoma	0.00242	0.0144	CcSEcCtD
Vilazodone—Skin disorder—Vemurafenib—melanoma	0.00239	0.0143	CcSEcCtD
Vilazodone—Breast disorder—Temozolomide—melanoma	0.00231	0.0138	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00224	0.0134	CcSEcCtD
Vilazodone—Decreased appetite—Vemurafenib—melanoma	0.00214	0.0128	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00213	0.0127	CcSEcCtD
Vilazodone—Fatigue—Vemurafenib—melanoma	0.00212	0.0127	CcSEcCtD
Vilazodone—Pollakiuria—Temozolomide—melanoma	0.00204	0.0122	CcSEcCtD
Vilazodone—Erectile dysfunction—Temozolomide—melanoma	0.00204	0.0121	CcSEcCtD
Vilazodone—Hallucination—Carmustine—melanoma	0.00182	0.0109	CcSEcCtD
Vilazodone—Connective tissue disorder—Carmustine—melanoma	0.0018	0.0107	CcSEcCtD
Vilazodone—Asthenia—Vemurafenib—melanoma	0.00177	0.0105	CcSEcCtD
Vilazodone—Hallucination—Temozolomide—melanoma	0.00176	0.0105	CcSEcCtD
Vilazodone—Connective tissue disorder—Temozolomide—melanoma	0.00174	0.0104	CcSEcCtD
Vilazodone—Eye disorder—Carmustine—melanoma	0.00171	0.0102	CcSEcCtD
Vilazodone—Hyponatraemia—Docetaxel—melanoma	0.00171	0.0102	CcSEcCtD
Vilazodone—Diarrhoea—Vemurafenib—melanoma	0.00169	0.01	CcSEcCtD
Vilazodone—Migraine—Docetaxel—melanoma	0.00168	0.00999	CcSEcCtD
Vilazodone—Eye disorder—Temozolomide—melanoma	0.00166	0.00986	CcSEcCtD
Vilazodone—Cardiac disorder—Temozolomide—melanoma	0.00164	0.0098	CcSEcCtD
Vilazodone—Dizziness—Vemurafenib—melanoma	0.00163	0.0097	CcSEcCtD
Vilazodone—Mental disorder—Carmustine—melanoma	0.00161	0.00957	CcSEcCtD
Vilazodone—Malnutrition—Carmustine—melanoma	0.0016	0.00951	CcSEcCtD
Vilazodone—Vomiting—Vemurafenib—melanoma	0.00157	0.00933	CcSEcCtD
Vilazodone—Mental disorder—Temozolomide—melanoma	0.00155	0.00925	CcSEcCtD
Vilazodone—Malnutrition—Temozolomide—melanoma	0.00154	0.00919	CcSEcCtD
Vilazodone—Breast disorder—Docetaxel—melanoma	0.00154	0.00917	CcSEcCtD
Vilazodone—Dysgeusia—Temozolomide—melanoma	0.00151	0.009	CcSEcCtD
Vilazodone—Vision blurred—Carmustine—melanoma	0.0015	0.00896	CcSEcCtD
Vilazodone—Tremor—Carmustine—melanoma	0.0015	0.00891	CcSEcCtD
Vilazodone—Agitation—Carmustine—melanoma	0.00147	0.00874	CcSEcCtD
Vilazodone—Nausea—Vemurafenib—melanoma	0.00146	0.00872	CcSEcCtD
Vilazodone—Vision blurred—Temozolomide—melanoma	0.00145	0.00866	CcSEcCtD
Vilazodone—Tremor—Temozolomide—melanoma	0.00145	0.00861	CcSEcCtD
Vilazodone—Agitation—Temozolomide—melanoma	0.00142	0.00844	CcSEcCtD
Vilazodone—Convulsion—Carmustine—melanoma	0.00138	0.00824	CcSEcCtD
Vilazodone—Palpitations—Temozolomide—melanoma	0.00136	0.00812	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00136	0.0081	CcSEcCtD
Vilazodone—Paraesthesia—Bleomycin—melanoma	0.00134	0.00798	CcSEcCtD
Vilazodone—Convulsion—Temozolomide—melanoma	0.00134	0.00796	CcSEcCtD
Vilazodone—Arthralgia—Temozolomide—melanoma	0.00131	0.00782	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0013	0.00777	CcSEcCtD
Vilazodone—Decreased appetite—Bleomycin—melanoma	0.0013	0.00773	CcSEcCtD
Vilazodone—Dry mouth—Temozolomide—melanoma	0.00128	0.00765	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00127	0.00755	CcSEcCtD
Vilazodone—Nervous system disorder—Temozolomide—melanoma	0.00123	0.00735	CcSEcCtD
Vilazodone—Feeling abnormal—Bleomycin—melanoma	0.00123	0.00733	CcSEcCtD
Vilazodone—Skin disorder—Temozolomide—melanoma	0.00122	0.00728	CcSEcCtD
Vilazodone—Hyperhidrosis—Temozolomide—melanoma	0.00122	0.00725	CcSEcCtD
Vilazodone—Decreased appetite—Dactinomycin—melanoma	0.00121	0.00721	CcSEcCtD
Vilazodone—Fatigue—Dactinomycin—melanoma	0.0012	0.00715	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Carmustine—melanoma	0.00119	0.00707	CcSEcCtD
Vilazodone—Insomnia—Carmustine—melanoma	0.00118	0.00702	CcSEcCtD
Vilazodone—Paraesthesia—Carmustine—melanoma	0.00117	0.00697	CcSEcCtD
Vilazodone—Somnolence—Carmustine—melanoma	0.00116	0.0069	CcSEcCtD
Vilazodone—Connective tissue disorder—Docetaxel—melanoma	0.00116	0.0069	CcSEcCtD
Vilazodone—Feeling abnormal—Dactinomycin—melanoma	0.00115	0.00683	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00115	0.00683	CcSEcCtD
Vilazodone—Insomnia—Temozolomide—melanoma	0.00114	0.00678	CcSEcCtD
Vilazodone—Decreased appetite—Carmustine—melanoma	0.00113	0.00675	CcSEcCtD
Vilazodone—Paraesthesia—Temozolomide—melanoma	0.00113	0.00673	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Carmustine—melanoma	0.00112	0.0067	CcSEcCtD
Vilazodone—Somnolence—Temozolomide—melanoma	0.00112	0.00667	CcSEcCtD
Vilazodone—Dyspepsia—Temozolomide—melanoma	0.00111	0.0066	CcSEcCtD
Vilazodone—Eye disorder—Docetaxel—melanoma	0.0011	0.00656	CcSEcCtD
Vilazodone—Decreased appetite—Temozolomide—melanoma	0.00109	0.00652	CcSEcCtD
Vilazodone—Cardiac disorder—Docetaxel—melanoma	0.00109	0.00651	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Temozolomide—melanoma	0.00109	0.00647	CcSEcCtD
Vilazodone—Fatigue—Temozolomide—melanoma	0.00109	0.00647	CcSEcCtD
Vilazodone—Feeling abnormal—Carmustine—melanoma	0.00107	0.00639	CcSEcCtD
Vilazodone—Asthenia—Bleomycin—melanoma	0.00107	0.00638	CcSEcCtD
Vilazodone—Feeling abnormal—Temozolomide—melanoma	0.00104	0.00618	CcSEcCtD
Vilazodone—Mental disorder—Docetaxel—melanoma	0.00103	0.00615	CcSEcCtD
Vilazodone—Malnutrition—Docetaxel—melanoma	0.00103	0.00611	CcSEcCtD
Vilazodone—Dysgeusia—Docetaxel—melanoma	0.001	0.00598	CcSEcCtD
Vilazodone—Asthenia—Dactinomycin—melanoma	0.000999	0.00595	CcSEcCtD
Vilazodone—Diarrhoea—Dactinomycin—melanoma	0.000952	0.00567	CcSEcCtD
Vilazodone—Vomiting—Bleomycin—melanoma	0.000949	0.00565	CcSEcCtD
Vilazodone—Asthenia—Carmustine—melanoma	0.000935	0.00557	CcSEcCtD
Vilazodone—Palpitations—Docetaxel—melanoma	0.000906	0.0054	CcSEcCtD
Vilazodone—Asthenia—Temozolomide—melanoma	0.000903	0.00538	CcSEcCtD
Vilazodone—Diarrhoea—Carmustine—melanoma	0.000891	0.00531	CcSEcCtD
Vilazodone—Convulsion—Docetaxel—melanoma	0.000889	0.00529	CcSEcCtD
Vilazodone—Nausea—Bleomycin—melanoma	0.000886	0.00528	CcSEcCtD
Vilazodone—Vomiting—Dactinomycin—melanoma	0.000885	0.00527	CcSEcCtD
Vilazodone—Arthralgia—Docetaxel—melanoma	0.000873	0.0052	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000867	0.00517	CcSEcCtD
Vilazodone—Dizziness—Carmustine—melanoma	0.000861	0.00513	CcSEcCtD
Vilazodone—Diarrhoea—Temozolomide—melanoma	0.000861	0.00513	CcSEcCtD
Vilazodone—Dry mouth—Docetaxel—melanoma	0.000854	0.00509	CcSEcCtD
Vilazodone—Dizziness—Temozolomide—melanoma	0.000832	0.00496	CcSEcCtD
Vilazodone—Vomiting—Carmustine—melanoma	0.000828	0.00493	CcSEcCtD
Vilazodone—Nausea—Dactinomycin—melanoma	0.000827	0.00492	CcSEcCtD
Vilazodone—Nervous system disorder—Docetaxel—melanoma	0.000821	0.00489	CcSEcCtD
Vilazodone—Skin disorder—Docetaxel—melanoma	0.000813	0.00484	CcSEcCtD
Vilazodone—Vomiting—Temozolomide—melanoma	0.0008	0.00477	CcSEcCtD
Vilazodone—Nausea—Carmustine—melanoma	0.000774	0.00461	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000763	0.00454	CcSEcCtD
Vilazodone—Insomnia—Docetaxel—melanoma	0.000757	0.00451	CcSEcCtD
Vilazodone—Paraesthesia—Docetaxel—melanoma	0.000752	0.00448	CcSEcCtD
Vilazodone—Nausea—Temozolomide—melanoma	0.000748	0.00445	CcSEcCtD
Vilazodone—Somnolence—Docetaxel—melanoma	0.000744	0.00443	CcSEcCtD
Vilazodone—Dyspepsia—Docetaxel—melanoma	0.000737	0.00439	CcSEcCtD
Vilazodone—Decreased appetite—Docetaxel—melanoma	0.000728	0.00433	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Docetaxel—melanoma	0.000723	0.00431	CcSEcCtD
Vilazodone—Fatigue—Docetaxel—melanoma	0.000722	0.0043	CcSEcCtD
Vilazodone—Feeling abnormal—Docetaxel—melanoma	0.00069	0.00411	CcSEcCtD
Vilazodone—Asthenia—Docetaxel—melanoma	0.000601	0.00358	CcSEcCtD
Vilazodone—Diarrhoea—Docetaxel—melanoma	0.000573	0.00341	CcSEcCtD
Vilazodone—Dizziness—Docetaxel—melanoma	0.000554	0.0033	CcSEcCtD
Vilazodone—Vomiting—Docetaxel—melanoma	0.000532	0.00317	CcSEcCtD
Vilazodone—Nausea—Docetaxel—melanoma	0.000497	0.00296	CcSEcCtD
Vilazodone—HTR1A—Signaling Pathways—PTK2B—melanoma	4.59e-05	0.000416	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—RAC1—melanoma	4.58e-05	0.000414	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPAM—melanoma	4.49e-05	0.000407	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCA—melanoma	4.48e-05	0.000406	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAB2—melanoma	4.46e-05	0.000404	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GNA11—melanoma	4.46e-05	0.000404	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FLT1—melanoma	4.44e-05	0.000402	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CG—melanoma	4.4e-05	0.000399	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAP2K2—melanoma	4.38e-05	0.000397	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2R—melanoma	4.29e-05	0.000388	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CG—melanoma	4.23e-05	0.000383	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FOXO4—melanoma	4.2e-05	0.00038	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HDAC2—melanoma	4.2e-05	0.00038	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCR4—melanoma	4.2e-05	0.00038	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RAC1—melanoma	4.16e-05	0.000376	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDNRB—melanoma	4.15e-05	0.000376	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GNAQ—melanoma	4.15e-05	0.000376	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—melanoma	4.09e-05	0.00037	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTK2B—melanoma	4.03e-05	0.000365	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCB4—melanoma	4e-05	0.000362	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CG—melanoma	4e-05	0.000362	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNA11—melanoma	3.92e-05	0.000355	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAB2—melanoma	3.92e-05	0.000355	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FLT1—melanoma	3.9e-05	0.000353	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SYK—melanoma	3.9e-05	0.000353	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CD—melanoma	3.87e-05	0.00035	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CG—melanoma	3.87e-05	0.00035	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGFR—melanoma	3.83e-05	0.000347	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ITGAV—melanoma	3.83e-05	0.000347	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT3—melanoma	3.83e-05	0.000347	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLA2G6—melanoma	3.82e-05	0.000346	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC6A11—melanoma	3.76e-05	0.000341	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIP4K2A—melanoma	3.76e-05	0.000341	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CD—melanoma	3.72e-05	0.000337	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HDAC2—melanoma	3.69e-05	0.000334	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCR4—melanoma	3.69e-05	0.000334	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FOXO4—melanoma	3.69e-05	0.000334	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ALB—melanoma	3.67e-05	0.000333	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTAP—melanoma	3.66e-05	0.000331	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNAQ—melanoma	3.64e-05	0.00033	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SOCS1—melanoma	3.55e-05	0.000321	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAP2K1—melanoma	3.54e-05	0.00032	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—S100B—melanoma	3.54e-05	0.00032	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CD—melanoma	3.52e-05	0.000318	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CG—melanoma	3.51e-05	0.000318	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—VCAN—melanoma	3.43e-05	0.000311	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SYK—melanoma	3.43e-05	0.00031	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CD—melanoma	3.4e-05	0.000308	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ERBB4—melanoma	3.38e-05	0.000306	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	3.37e-05	0.000305	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITGAV—melanoma	3.36e-05	0.000304	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT3—melanoma	3.36e-05	0.000304	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGFR—melanoma	3.36e-05	0.000304	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN2B—melanoma	3.35e-05	0.000304	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PHGDH—melanoma	3.26e-05	0.000295	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LUM—melanoma	3.26e-05	0.000295	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CB—melanoma	3.24e-05	0.000294	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD86—melanoma	3.24e-05	0.000294	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CXCL8—melanoma	3.24e-05	0.000294	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EDN1—melanoma	3.22e-05	0.000291	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—melanoma	3.21e-05	0.000291	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HPSE—melanoma	3.2e-05	0.00029	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF1—melanoma	3.15e-05	0.000285	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CSF2—melanoma	3.15e-05	0.000285	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CUBN—melanoma	3.14e-05	0.000284	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS1—melanoma	3.11e-05	0.000282	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAP2K1—melanoma	3.11e-05	0.000281	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—S100B—melanoma	3.11e-05	0.000281	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—melanoma	3.1e-05	0.000281	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CD—melanoma	3.09e-05	0.000279	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—E2F1—melanoma	3.08e-05	0.000279	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CB—melanoma	3.06e-05	0.000277	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFRA—melanoma	3.05e-05	0.000276	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BSG—melanoma	3.03e-05	0.000275	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SDHD—melanoma	3.03e-05	0.000275	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CSPG4—melanoma	3.03e-05	0.000275	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ITGB3—melanoma	3.02e-05	0.000273	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCA—melanoma	3.02e-05	0.000273	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ERBB4—melanoma	2.97e-05	0.000269	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CB—melanoma	2.96e-05	0.000268	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SPP1—melanoma	2.96e-05	0.000268	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAP2K2—melanoma	2.95e-05	0.000267	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN2B—melanoma	2.94e-05	0.000267	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CXCL8—melanoma	2.94e-05	0.000267	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPAM—melanoma	2.94e-05	0.000266	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP17A1—melanoma	2.9e-05	0.000262	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD86—melanoma	2.85e-05	0.000258	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCL8—melanoma	2.85e-05	0.000258	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDN1—melanoma	2.83e-05	0.000256	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—melanoma	2.81e-05	0.000255	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TERT—melanoma	2.8e-05	0.000254	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTEN—melanoma	2.8e-05	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RAC1—melanoma	2.8e-05	0.000253	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CSF2—melanoma	2.76e-05	0.00025	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF1—melanoma	2.76e-05	0.00025	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GNA11—melanoma	2.73e-05	0.000248	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—melanoma	2.72e-05	0.000246	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—E2F1—melanoma	2.7e-05	0.000245	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CB—melanoma	2.69e-05	0.000244	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HIF1A—melanoma	2.68e-05	0.000243	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—FASN—melanoma	2.68e-05	0.000242	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFRA—melanoma	2.67e-05	0.000242	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITGB3—melanoma	2.65e-05	0.00024	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCA—melanoma	2.65e-05	0.00024	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC5A5—melanoma	2.63e-05	0.000238	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SPP1—melanoma	2.6e-05	0.000235	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAP2K2—melanoma	2.59e-05	0.000234	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCL8—melanoma	2.59e-05	0.000234	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KDR—melanoma	2.56e-05	0.000232	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CD44—melanoma	2.54e-05	0.00023	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GNAQ—melanoma	2.54e-05	0.00023	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLA2G6—melanoma	2.5e-05	0.000226	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—melanoma	2.47e-05	0.000224	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FN1—melanoma	2.47e-05	0.000223	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TERT—melanoma	2.46e-05	0.000223	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RAC1—melanoma	2.45e-05	0.000222	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP1B1—melanoma	2.44e-05	0.000221	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH1—melanoma	2.42e-05	0.000219	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD80—melanoma	2.37e-05	0.000214	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APC—melanoma	2.36e-05	0.000214	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KIT—melanoma	2.36e-05	0.000214	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—melanoma	2.36e-05	0.000214	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—NRAS—melanoma	2.36e-05	0.000214	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HIF1A—melanoma	2.35e-05	0.000213	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGF—melanoma	2.33e-05	0.000211	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK3—melanoma	2.26e-05	0.000205	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KDR—melanoma	2.25e-05	0.000204	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—VCAN—melanoma	2.24e-05	0.000203	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BRAF—melanoma	2.22e-05	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FN1—melanoma	2.17e-05	0.000196	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—melanoma	2.16e-05	0.000196	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK1—melanoma	2.15e-05	0.000195	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EGFR—melanoma	2.15e-05	0.000195	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH1—melanoma	2.12e-05	0.000192	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAP2K1—melanoma	2.09e-05	0.000189	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD80—melanoma	2.08e-05	0.000188	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CD—melanoma	2.08e-05	0.000188	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KIT—melanoma	2.07e-05	0.000188	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APC—melanoma	2.07e-05	0.000188	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—melanoma	2.07e-05	0.000188	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—NRAS—melanoma	2.07e-05	0.000188	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	2.06e-05	0.000186	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGF—melanoma	2.05e-05	0.000186	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KRAS—melanoma	2.03e-05	0.000184	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCB1—melanoma	2.01e-05	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF2—melanoma	1.99e-05	0.00018	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK3—melanoma	1.99e-05	0.00018	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—melanoma	1.98e-05	0.000179	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BRAF—melanoma	1.95e-05	0.000176	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—melanoma	1.9e-05	0.000172	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP17A1—melanoma	1.89e-05	0.000171	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK1—melanoma	1.89e-05	0.000171	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EGFR—melanoma	1.89e-05	0.000171	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.87e-05	0.000169	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MDM2—melanoma	1.86e-05	0.000168	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PRKCA—melanoma	1.85e-05	0.000167	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAP2K1—melanoma	1.84e-05	0.000166	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ERBB2—melanoma	1.83e-05	0.000166	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ERCC2—melanoma	1.83e-05	0.000166	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CD—melanoma	1.82e-05	0.000165	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.81e-05	0.000164	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—melanoma	1.81e-05	0.000163	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GNA11—melanoma	1.79e-05	0.000162	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KRAS—melanoma	1.78e-05	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FASN—melanoma	1.75e-05	0.000158	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF2—melanoma	1.75e-05	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL8—melanoma	1.74e-05	0.000157	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HRAS—melanoma	1.73e-05	0.000156	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC5A5—melanoma	1.72e-05	0.000156	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.7e-05	0.000154	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.68e-05	0.000152	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—melanoma	1.66e-05	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—melanoma	1.66e-05	0.00015	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GNAQ—melanoma	1.66e-05	0.00015	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CD44—melanoma	1.66e-05	0.00015	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—melanoma	1.65e-05	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—melanoma	1.64e-05	0.000148	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MDM2—melanoma	1.63e-05	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCND1—melanoma	1.62e-05	0.000147	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—melanoma	1.62e-05	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ERBB2—melanoma	1.61e-05	0.000146	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CTNNB1—melanoma	1.6e-05	0.000145	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP1B1—melanoma	1.59e-05	0.000144	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CB—melanoma	1.59e-05	0.000144	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—melanoma	1.57e-05	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1A—melanoma	1.57e-05	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTEN—melanoma	1.56e-05	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NFKB1—melanoma	1.56e-05	0.000141	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL8—melanoma	1.53e-05	0.000138	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—melanoma	1.53e-05	0.000138	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HRAS—melanoma	1.52e-05	0.000137	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1B—melanoma	1.49e-05	0.000135	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—melanoma	1.48e-05	0.000134	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—melanoma	1.46e-05	0.000132	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—melanoma	1.46e-05	0.000132	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—melanoma	1.45e-05	0.000131	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—melanoma	1.45e-05	0.000131	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCND1—melanoma	1.42e-05	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—melanoma	1.41e-05	0.000128	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CTNNB1—melanoma	1.41e-05	0.000128	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—melanoma	1.4e-05	0.000127	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—melanoma	1.4e-05	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NRAS—melanoma	1.4e-05	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—melanoma	1.38e-05	0.000125	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1A—melanoma	1.38e-05	0.000125	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTEN—melanoma	1.37e-05	0.000124	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NFKB1—melanoma	1.37e-05	0.000124	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—melanoma	1.34e-05	0.000121	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK3—melanoma	1.34e-05	0.000121	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCB1—melanoma	1.31e-05	0.000119	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—melanoma	1.3e-05	0.000118	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CD—melanoma	1.27e-05	0.000115	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK1—melanoma	1.27e-05	0.000115	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGFR—melanoma	1.27e-05	0.000115	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—melanoma	1.26e-05	0.000114	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—melanoma	1.24e-05	0.000112	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—melanoma	1.23e-05	0.000111	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NRAS—melanoma	1.23e-05	0.000111	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PRKCA—melanoma	1.21e-05	0.000109	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KRAS—melanoma	1.2e-05	0.000109	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ERCC2—melanoma	1.2e-05	0.000108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK3—melanoma	1.17e-05	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—melanoma	1.14e-05	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK1—melanoma	1.12e-05	0.000101	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGFR—melanoma	1.12e-05	0.000101	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CB—melanoma	1.11e-05	0.0001	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—melanoma	1.1e-05	9.99e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—melanoma	1.1e-05	9.95e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—melanoma	1.07e-05	9.66e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KRAS—melanoma	1.05e-05	9.55e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRAS—melanoma	1.02e-05	9.24e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—melanoma	9.77e-06	8.85e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—melanoma	9.69e-06	8.77e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTEN—melanoma	9.58e-06	8.67e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—melanoma	9.46e-06	8.56e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—melanoma	9.37e-06	8.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—melanoma	9.13e-06	8.27e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—melanoma	9.01e-06	8.16e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRAS—melanoma	8.96e-06	8.11e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—melanoma	8.58e-06	7.77e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CD—melanoma	8.32e-06	7.53e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—melanoma	8.21e-06	7.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—melanoma	7.91e-06	7.17e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CB—melanoma	7.25e-06	6.56e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—melanoma	7.18e-06	6.5e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—melanoma	6.76e-06	6.12e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTEN—melanoma	6.26e-06	5.67e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—melanoma	5.52e-06	5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—melanoma	4.42e-06	4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—melanoma	3.61e-06	3.27e-05	CbGpPWpGaD
